This brief is intended to provide an update on the current state of opioid overdose and outpatient buprenorphine treatment in the United States. The brief will focus on disparities in treatment access and fatal overdose, as well as on opportunities to close care gaps and make buprenorphine treatment more accessible to people experiencing homelessness. Download […]
Opioid Overdose and Buprenorphine Access – 2024 Update Read More >>
People using fentanyl are losing hope — many think they can’t get on buprenorphine, and that bupe isn’t strong enough to help them feel OK without fent. In this workshop we will prepare medical providers to support patients starting bupe, from pre-induction preparation, to choosing an option for induction, to aftercare in a variety of
Fent to Bupe: Paths to Success from Camp to Clinic Read More >>
People experiencing homelessness experience high rates of alcohol use disorder, estimated to be as high as 40%, and increased morbidity and mortality from alcohol use, as well as increased barriers to treatment including limited financial resources, limited insurance coverage, photo ID requirements, comorbid physical and mental health conditions, and stigma. The most accessible place for
Treating Alcohol Use Disorder in the Primary Care Setting Read More >>
Xylazine (“Tranq”) first appeared in the opioid drug supply over a decade ago, however, it has now infiltrated over 90% of the drug supply in one large city. This presentation will discuss how the increase in xylazine has impacted the health care concerns among people experiencing homeless (PEH) in several areas: pregnancy/prenatal care, wounds, and
Emerging Health Care Concerns Among People Experiencing Homeless Who Use Xylazine Read More >>
In 2022, the National Health Care for the Homeless Council chaired the development of the Caucus on Homelessness (CoH) program for the American Public Health Association (APHA) 2022 Annual Meeting and Expo. The theme of the annual meeting was: “150 Years of Creating the Healthiest Nation: Leading the Path Toward Equity.” Social equity is, as
APHA 2022 Annual Meeting and Expo Summary Read More >>
Webinar Slides(PDF) NHCHC MAT Policy Brief(PDF) Project HOPE Medication First Model(PDF) Project HOPE Addiction Laguage Guide(PDF) Buprenorphine Research on New Approaches article(PDF) While Health Care for the Homeless programs serve only 4% of all health center patients nationally, they are responsible for serving nearly 40% of all patients receiving medication-assisted treatment (MAT). Patient need
Medication-Assisted Treatment in the HCH Community: Strategies for Expanding Services Read More >>
Webinar Slides(PDF) The Comprehensive Addiction and Recovery Act of 2016 (CARA) expanded buprenorphine prescribing rights to nurse practitioners and physicians’ assistants, while changes in federal regulations increased patient limits. At the same time, many homeless health care providers have been adding MAT services into their primary care practice and finding both challenges and opportunities with
Webinar Slides(PDF) Our nation is facing an opioid epidemic that has reached crisis levels; drug overdose deaths have surpassed car accidents and firearms as the leading cause of injury and death in the U.S. In 2014 47,000 people died of drug overdoses, more than any other year on record, and opiate overdoses accounted for more
